{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:55:20Z","timestamp":1791338120462,"version":"4.3.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T00:00:00Z","timestamp":1716940800000},"content-version":"am","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100012774","name":"Innovationsfonden","doi-asserted-by":"publisher","award":["17\/EE\/0484"],"award-info":[{"award-number":["17\/EE\/0484"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovationsfonden","doi-asserted-by":"publisher","award":["4108-00004B"],"award-info":[{"award-number":["4108-00004B"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K022202\/1"],"award-info":[{"award-number":["MR\/K022202\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000737","name":"University of Exeter","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000764","name":"King's College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009360","name":"King\u2019s College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009360","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.biopsych.2022.10.012","type":"journal-article","created":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T17:47:50Z","timestamp":1667065670000},"page":"1089-1098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Brain Serotonin Release Is Reduced in Patients With Depression: A [11C]Cimbi-36 Positron Emission Tomography Study With a d-Amphetamine Challenge"],"prefix":"10.1016","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7022-6211","authenticated-orcid":false,"given":"David","family":"Erritzoe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata R.","family":"Godlewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham E.","family":"Searle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Agnorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishekh H.","family":"Ashok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Colasanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iro","family":"Boura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hollie","family":"Parfitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Howes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Passchier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger N.","family":"Gunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Politis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Nutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Cowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitte M.","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenii A.","family":"Rabiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2022.10.012_bib1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries (1990-2013): a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.biopsych.2022.10.012_bib2","doi-asserted-by":"crossref","first-page":"772","DOI":"10.7326\/0003-4819-155-11-201112060-00009","article-title":"Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: An updated meta-analysis","volume":"155","author":"Gartlehner","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.biopsych.2022.10.012_bib3","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1176\/ps.2009.60.11.1439","article-title":"What did STAR\u2217D teach us? Results from a large-scale, practical, clinical trial for patients with depression","volume":"60","author":"Gaynes","year":"2009","journal-title":"Psychiatr Serv"},{"issue":"suppl 4","key":"10.1016\/j.biopsych.2022.10.012_bib4","first-page":"22","article-title":"Monoamine depletion studies: Implications for antidepressant discontinuation syndrome","volume":"67","author":"Delgado","year":"2006","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.012_bib5","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1192\/bjp.113.505.1407","article-title":"5-Hydroxytryptamine in the hind-brain of depressive suicides","volume":"113","author":"Shaw","year":"1967","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.012_bib6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/wps.20229","article-title":"What has serotonin to do with depression?","volume":"14","author":"Cowen","year":"2015","journal-title":"World Psychiatry"},{"issue":"suppl 2","key":"10.1016\/j.biopsych.2022.10.012_bib7","first-page":"123","article-title":"Mechanism of action of antidepressants","volume":"36","author":"Artigas","year":"2002","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.biopsych.2022.10.012_bib8","first-page":"239","article-title":"Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients","volume":"1","author":"Shopsin","year":"1975","journal-title":"Psychopharmacol Commun"},{"key":"10.1016\/j.biopsych.2022.10.012_bib9","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/archpsyc.1976.01770070041003","article-title":"Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients","volume":"33","author":"Shopsin","year":"1976","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.012_bib10","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0140-6736(96)07044-4","article-title":"Relapse of depression after rapid depletion of tryptophan","volume":"349","author":"Smith","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.biopsych.2022.10.012_bib11","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0006-3223(99)00014-1","article-title":"Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: Implications for the role of serotonin in the mechanism of antidepressant action","volume":"46","author":"Delgado","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.012_bib12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.mp.4001949","article-title":"Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: A meta-analysis of monoamine depletion studies","volume":"12","author":"Ruh\u00e9","year":"2007","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.012_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12457-6","article-title":"Separate neural representations of depression, anxiety and apathy in Parkinson\u2019s disease","volume":"7","author":"Dan","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.biopsych.2022.10.012_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ana.24859","article-title":"Serotonin transporter in Parkinson\u2019s disease: A meta-analysis of positron emission tomography studies","volume":"81","author":"Pagano","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2022.10.012_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.biopsych.2022.10.012_bib16","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1177\/0271678X20982389","article-title":"Parkinson patients have a presynaptic serotonergic deficit: A dynamic deep brain stimulation PET study","volume":"41","author":"J\u00f8rgensen","year":"2021","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2022.10.012_bib17","article-title":"The serotonin theory of depression: A systematic umbrella review of the evidence [published online Jul 20]","author":"Moncrieff","year":"2022","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.012_bib18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1177\/0271678X16629483","article-title":"Cerebral 5-HT release correlates with [(11)C]Cimbi36 PET measures of 5-HT2A receptor occupancy in the pig brain","volume":"37","author":"J\u00f8rgensen","year":"2017","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2022.10.012_bib19","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1007\/s00213-015-3938-6","article-title":"Application of cross-species PET imaging to assess neurotransmitter release in brain","volume":"232","author":"Finnema","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2022.10.012_bib20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/jcbfm.2011.115","article-title":"Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humans","volume":"32","author":"Shotbolt","year":"2012","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2022.10.012_bib21","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/s41386-019-0567-5","article-title":"Serotonin release measured in the human brain: A PET study with [(11)C]CIMBI-36 and d-amphetamine challenge","volume":"45","author":"Erritzoe","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2022.10.012_bib22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/sj.bjp.0702067","article-title":"A\u00a0comparison of the effects on central 5-HT function of sibutramine hydrochloride and other weight-modifying agents","volume":"125","author":"Heal","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopsych.2022.10.012_bib23","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1523\/JNEUROSCI.15-02-01308.1995","article-title":"Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine","volume":"15","author":"Kuczenski","year":"1995","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2022.10.012_bib24","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41398-018-0178-7","article-title":"Serotonin concentration enhancers at clinically relevant doses reduce [11C]AZ10419369 binding to the 5-HT1B receptors in the nonhuman primate brain","volume":"8","author":"Yang","year":"2018","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.012_bib25","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/j.1476-5381.2011.01499.x","article-title":"Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats","volume":"164","author":"Kehr","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopsych.2022.10.012_bib26","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/s41598-021-81454-7","article-title":"The role of dorsolateral and ventromedial prefrontal cortex in the processing of emotional dimensions","volume":"11","author":"Nejati","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.biopsych.2022.10.012_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41386-021-01101-7","article-title":"Prefrontal cortex and depression","volume":"47","author":"Pizzagalli","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2022.10.012_bib28","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","article-title":"Development of a rating scale for primary depressive illness","volume":"6","author":"Hamilton","year":"1967","journal-title":"Br J Soc Clin Psychol"},{"key":"10.1016\/j.biopsych.2022.10.012_bib29","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/01.WCB.0000038000.34930.4E","article-title":"Strategies to improve neuroreceptor parameter estimation by linear regression analysis","volume":"22","author":"Ichise","year":"2002","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2022.10.012_bib30","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1126\/science.333584","article-title":"Some thoughts on clinical trials, especially problems of multiplicity","volume":"198","author":"Tukey","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2022.10.012_bib31","first-page":"120","article-title":"A\u00a0high-resolution in\u00a0vivo atlas of the human Brain\u2019s serotonin system","volume":"37","author":"Beliveau","year":"2017","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2022.10.012_bib32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neuroimage.2016.02.001","article-title":"Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test\u2013retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin","volume":"130","author":"Ettrup","year":"2016","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2022.10.012_bib33","first-page":"440","article-title":"Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications","volume":"178","author":"Toll","year":"1998","journal-title":"NIDA Res Monogr"},{"key":"10.1016\/j.biopsych.2022.10.012_bib34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/syn.21835","article-title":"Optimising PET approaches to measuring 5-HT release in human brain","volume":"69","author":"Tyacke","year":"2015","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2022.10.012_bib35","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00259-010-1686-8","article-title":"Radiosynthesis and in\u00a0vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT2A agonist PET tracers","volume":"38","author":"Ettrup","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.biopsych.2022.10.012_bib36","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1038\/npp.2011.105","article-title":"The reduction of R1, a novel repressor protein for monoamine oxidase A, in major depressive disorder","volume":"36","author":"Johnson","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2022.10.012_bib37","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/archgenpsychiatry.2009.156","article-title":"Brain monoamine oxidase A binding in major depressive disorder: Relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence","volume":"66","author":"Meyer","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.012_bib38","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/archpsyc.63.11.1209","article-title":"Elevated monoamine oxidase A levels in the brain: An explanation for the monoamine imbalance of major depression","volume":"63","author":"Meyer","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.012_bib39","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.nbd.2012.06.001","article-title":"Neuroreceptor imaging in depression","volume":"52","author":"Savitz","year":"2013","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.biopsych.2022.10.012_bib40","doi-asserted-by":"crossref","first-page":"10520","DOI":"10.1523\/JNEUROSCI.4388-06.2007","article-title":"Vmat2 heterozygous mutant mice display a depressive-like phenotype","volume":"27","author":"Fukui","year":"2007","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2022.10.012_bib41","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.1523\/JNEUROSCI.1495-09.2009","article-title":"Nonmotor symptoms of Parkinson\u2019s disease revealed in an animal model with reduced monoamine storage capacity","volume":"29","author":"Taylor","year":"2009","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2022.10.012_bib42","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1038\/npp.2011.142","article-title":"Severe serotonin depletion after conditional deletion of the vesicular monoamine transporter 2 gene in serotonin neurons: Neural and behavioral consequences","volume":"36","author":"Narboux-N\u00eame","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2022.10.012_bib43","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.nucmedbio.2007.06.008","article-title":"Serotonin-1A receptor imaging in recurrent depression: Replication and literature review","volume":"34","author":"Drevets","year":"2007","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.biopsych.2022.10.012_bib44","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/sj.mp.4001401","article-title":"Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635","volume":"9","author":"Bhagwagar","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.012_bib45","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.biopsych.2009.01.028","article-title":"Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression","volume":"66","author":"Sullivan","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.012_bib46","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/mds.23895","article-title":"Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson\u2019s disease","volume":"27","author":"Ballanger","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.biopsych.2022.10.012_bib47","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1523\/JNEUROSCI.2852-09.2010","article-title":"A\u00a0nonlinear relationship between cerebral serotonin transporter and 5-HT(2A) receptor binding: An in\u00a0vivo molecular imaging study in humans","volume":"30","author":"Erritzoe","year":"2010","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2022.10.012_bib48","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1176\/appi.ajp.160.1.90","article-title":"Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm","volume":"160","author":"Meyer","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.012_bib49","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1176\/ajp.2006.163.9.1580","article-title":"Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: A positron emission study with [(11)C]MDL 100,907","volume":"163","author":"Bhagwagar","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.012_bib50","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1192\/bjp.171.5.444","article-title":"Serotonin 5-HT2 receptor imaging in major depression: Focal changes in orbito-insular cortex","volume":"171","author":"Biver","year":"1997","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.012_bib51","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0006-3223(98)00007-9","article-title":"The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine","volume":"45","author":"Attar-L\u00e9vy","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.012_bib52","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1001\/archpsyc.57.9.850","article-title":"Brain serotonin2 receptors in major depression: A positron emission tomography study","volume":"57","author":"Yatham","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.012_bib53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.biopsych.2003.08.015","article-title":"Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: In\u00a0vivo measurement with [18F]altanserin positron emission tomography","volume":"55","author":"Mintun","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.012_bib54","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00213-002-1379-5","article-title":"5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: A PET study","volume":"167","author":"Messa","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2022.10.012_bib55","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1176\/ajp.156.7.1029","article-title":"Prefrontal cortex 5-HT2 receptors in depression: An [18F]setoperone PET imaging study","volume":"156","author":"Meyer","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.012_bib56","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.biopsych.2007.07.009","article-title":"Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder","volume":"63","author":"Frokjaer","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.012_bib57","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/npp.2009.218","article-title":"Familial risk for mood disorder and the personality risk factor, neuroticism, interact in their association with frontolimbic serotonin 2A receptor binding","volume":"35","author":"Frokjaer","year":"2010","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2022.10.012_bib58","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.5665\/sleep.2230","article-title":"Sleep deprivation increases cerebral serotonin 2A receptor binding in humans","volume":"35","author":"Elmenhorst","year":"2012","journal-title":"Sleep"},{"key":"10.1016\/j.biopsych.2022.10.012_bib59","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pscychresns.2009.08.007","article-title":"Gender, personality, and serotonin-2A receptor binding in healthy subjects","volume":"181","author":"Soloff","year":"2010","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2022.10.012_bib60","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1176\/appi.ajp.158.1.78","article-title":"The effect of paroxetine on 5-HT(2A) receptors in depression: An [(18)F]setoperone PET imaging study","volume":"158","author":"Meyer","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2022.10.012_bib61","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1016\/S0021-9258(18)53442-6","article-title":"A\u00a0mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model","volume":"268","author":"Samama","year":"1993","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2022.10.012_bib62","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/sj.bjp.0706073","article-title":"Mechanisms of inverse agonist action at D2 dopamine receptors","volume":"145","author":"Roberts","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopsych.2022.10.012_bib63","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/syn.20325","article-title":"Dopamine (D2\/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in\u00a0vivo","volume":"60","author":"Narendran","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2022.10.012_bib64","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/00004647-200205000-00011","article-title":"Specific binding of [(11)C]Raclopride and N -[(3)H]propyl-norapomorphine to dopamine receptors in living mouse Striatum: Occupancy by endogenous dopamine and guanosine triphosphate-free G protein","volume":"22","author":"Cumming","year":"2002","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2022.10.012_bib65","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0026-895X(25)08918-7","article-title":"Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors","volume":"42","author":"Leonhardt","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.biopsych.2022.10.012_bib66","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0026-895X(25)09516-1","article-title":"4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: Evidence for multiple states and not multiple 5HT2 receptor subtypes","volume":"38","author":"Teitler","year":"1990","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.biopsych.2022.10.012_bib67","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/(SICI)1098-2396(200002)35:2<144::AID-SYN7>3.0.CO;2-K","article-title":"Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT(2A) and 5-HT(2C) receptors","volume":"35","author":"Egan","year":"2000","journal-title":"Synapse"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322322017048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322322017048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:09:19Z","timestamp":1762099759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322322017048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":67,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0006322322017048"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2022.10.012","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain Serotonin Release Is Reduced in Patients With Depression: A [11C]Cimbi-36 Positron Emission Tomography Study With a d-Amphetamine Challenge","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2022.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc on behalf of Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}